Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni B Gaeta

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|September 26, 2008
Telbivudine: Taking into account baseline and on-therapy predictorsGiovanni B Gaeta
International Journal of Antimicrobial Agents|September 22, 2019
Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfectionGiuseppina Brancaccio, Giovanni B Gaeta
Annals of Transplantation|April 2, 2020
Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?Giuseppina Brancaccio, Giovanni B Gaeta
Alimentary Pharmacology & Therapeutics|January 29, 2020
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting-authors' replyGiuseppina Brancaccio, Giovanni B Gaeta
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2019
Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV?Paolo Maggi, Giuseppina Brancaccio, Giovanni B Gaeta
Nuclear Medicine Communications|February 16, 2006
Fever of unknown origin: a systematic review of the literature for 1995-2004Giovanni B Gaeta, Francesco M Fusco, Salvatore Nardiello
Le Infezioni in Medicina|June 13, 2022
Recent breakthroughs in the treatment of chronic hepatitis DeltaGiuseppina Brancaccio, Laura Gaeta, Alessandro Vitale, et al.
Hepatology (Baltimore, Md.)|September 27, 2007
Hepatitis delta in Europe: vanishing or refreshing?Giovanni B Gaeta, Tommaso Stroffolini, Antonina Smedile, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in ItalyGiorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al.
Infectious Diseases (London, England)|May 14, 2020
Changing indications for liver transplant: slow decline of hepatitis viruses in ItalyGiuseppina Brancaccio, Alessandro Vitale, Giuseppe Signoriello, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|September 26, 2008
Telbivudine: Taking into account baseline and on-therapy predictorsGiovanni B Gaeta
International Journal of Antimicrobial Agents|September 22, 2019
Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfectionGiuseppina Brancaccio, Giovanni B Gaeta
Annals of Transplantation|April 2, 2020
Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?Giuseppina Brancaccio, Giovanni B Gaeta
Alimentary Pharmacology & Therapeutics|January 29, 2020
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting-authors' replyGiuseppina Brancaccio, Giovanni B Gaeta
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2019
Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV?Paolo Maggi, Giuseppina Brancaccio, Giovanni B Gaeta
Nuclear Medicine Communications|February 16, 2006
Fever of unknown origin: a systematic review of the literature for 1995-2004Giovanni B Gaeta, Francesco M Fusco, Salvatore Nardiello
Le Infezioni in Medicina|June 13, 2022
Recent breakthroughs in the treatment of chronic hepatitis DeltaGiuseppina Brancaccio, Laura Gaeta, Alessandro Vitale, et al.
Hepatology (Baltimore, Md.)|September 27, 2007
Hepatitis delta in Europe: vanishing or refreshing?Giovanni B Gaeta, Tommaso Stroffolini, Antonina Smedile, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in ItalyGiorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al.
Infectious Diseases (London, England)|May 14, 2020
Changing indications for liver transplant: slow decline of hepatitis viruses in ItalyGiuseppina Brancaccio, Alessandro Vitale, Giuseppe Signoriello, et al.
Pageof 5